CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 84 enrolled
Drug / intervention
Whitfield solution +2 moredrug
Likely dose
Whitfield solution 60 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05901961
NCT05901961Phase 4Completed

A Study of Effectiveness and Safety of Whitfield's Solution, Zinc Oxide Nanoparticles Solution and the Combination of Whitfield's and Zinc Oxide Nanoparticles Solution for the Treatment of Fungal Feet Infection

Mahidol University·interventional·Posted Jun 13, 2023·Updated Mar 27, 2024

In Brief

A Phase 4 clinical trial evaluating Whitfield solution, Zinc oxide nanoparticles solution, and 1 other intervention for Fungal Foot Infection. Completed, enrolled 84 participants across 1 site.

Detailed Summary

This study aimed to study the efficacy of Whitfield's solution, zinc oxide nanoparticles solution, and the combination of Whitfield's and zinc oxide nanoparticles solution in treating fungal feet infection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesThailand

Timeline

Phase 4CompletedFinished
202420252026
First PostedJun 13, 2023
Enrollment StartJun 2, 2023
Primary CompletionSep 9, 2023
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 3.1 years ago

Interventions

Whitfield solutiondrug

The patient will receive 60 mL of Whitfield solution. They will be instructed to apply 0.5 mL of the solution to the lesion twice daily for a consecutive period of 8 weeks.

Zinc oxide nanoparticles solutiondrug

The patient will receive 60 mL of 1% Zinc oxide nanoparticles solution. They will be instructed to apply 0.5 mL of the solution to the lesion twice daily for a consecutive period of 8 weeks.

Combined Whitfield and Zinc oxide nanoparticles solutiondrug

The patient will receive 60 mL of combined Whitfield and Zinc oxide nanoparticles solution. They will be instructed to apply 0.5 mL of the solution to the lesion twice daily for a consecutive period of 8 weeks.